NGM Biopharmaceuticals Analysis
NGM Biopharmaceuticals is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of NGM Biopharmaceutica delisted stock analysis is to determine its intrinsic value, which is an estimate of what NGM Biopharmaceuticals is worth, separate from its market price. There are two main types of NGM Biopharmaceutica's stock analysis: fundamental analysis and technical analysis.
The NGM Biopharmaceutica stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. NGM Biopharmaceutica is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. NGM Stock trading window is adjusted to America/New York timezone.
NGM |
NGM Stock Analysis Notes
About 21.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.86. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NGM Biopharmaceuticals recorded a loss per share of 1.73. The entity had not issued any dividends in recent years. NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California. Ngm Biopharmaceutica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 225 people. To find out more about NGM Biopharmaceuticals contact David Woodhouse at 650 243 5555 or learn more at https://www.ngmbio.com.NGM Biopharmaceuticals Investment Alerts
| NGM Biopharmaceutica is not yet fully synchronised with the market data | |
| NGM Biopharmaceutica has some characteristics of a very speculative penny stock | |
| NGM Biopharmaceutica has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 4.42 M. Reported Net Loss for the year was (142.38 M) with loss before taxes, overhead, and interest of (125.73 M). | |
| NGM Biopharmaceuticals has about 297.81 M in cash with (132.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.71. | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders |
NGM Biopharmaceuticals Upcoming and Recent Events
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
NGM Market Capitalization
The company currently falls under 'Small-Cap' category with a total capitalization of 128.53 M.NGM Biopharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NGM Biopharmaceutica insiders, such as employees or executives, is commonly permitted as long as it does not rely on NGM Biopharmaceutica's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases NGM Biopharmaceutica insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Goeddel David V over six months ago Acquisition by Goeddel David V of 5840 shares of NGM Biopharmaceutica at 0.6211 subject to Rule 16b-3 | ||
David Woodhouse over a year ago Payment of 13032 shares by David Woodhouse of NGM Biopharmaceutica subject to Rule 16b-3 | ||
Viret Jeanfrederic over a year ago Acquisition by Viret Jeanfrederic of 450000 shares of NGM Biopharmaceutica subject to Rule 16b-3 | ||
Viret Jeanfrederic over a year ago NGM Biopharmaceutica exotic insider transaction detected | ||
David Woodhouse over a year ago Acquisition by David Woodhouse of 127200 shares of NGM Biopharmaceutica subject to Rule 16b-3 |
NGM Biopharmaceutica Outstanding Bonds
NGM Biopharmaceutica issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. NGM Biopharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NGM bonds can be classified according to their maturity, which is the date when NGM Biopharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding NGM Biopharmaceutica to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in NGM Stock
If you are still planning to invest in NGM Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NGM Biopharmaceutica's history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |